Royalty Pharma is trading 4% up today at $58.56, outperforming a weak broader market where major indices are trading lower.
- The move is tied to a rally in the healthcare sector, which is up over 2% following strong UnitedHealth earnings.
- Positive developments at other large pharmaceutical companies are contributing to sector-wide risk-on sentiment.
- There is no fresh company-specific news or analyst commentary today to account for the price action.